New hope in treating Huntington’s disease and a report card on RFK Jr.’s promises

The Food and Drug Administration (FDA) reversed its opposition to a gene therapy for Huntington's disease this week, potentially clearing the way for its maker, UniQure, to seek U.S. approval. This development offers new hope for individuals affected by the neurodegenerative disorder. Lauren Holder, a Huntington's disease advocate living with the early stages of the condition, joined "The Readout LOUD" podcast to discuss the implications of this FDA decision and its significance for the Huntington's community. The podcast also provided an update on Robert F. Kennedy Jr.'s initiatives aimed at reforming healthcare in America.